Evaluating the efficacy of a neurosensine-enriched dermocosmetic in patients with sensitive skin and/or allergies: a one-month observational study

A. Liakou, C. Stanescu, S. Pucher, M. La Forgia, M. Nioré, S. Salah, D. Kerob

  • 10min
  • Oct. 2023
  • Supported by
  • La Roche-Posay
EADV Image

INTRODUCTION


Sensitive skin and allergies are influenced by various factors, including demographic characteristics, environmental triggers, and living conditions. Specific dermocosmetic products (DC) are designed to alleviate symptoms associated with these conditions. In this study, our objectives are to describe the baseline profile of patients with sensitive or intolerant skin and allergies (demography, main triggers, living environment, type of allergy) and assess the efficacy of a DC after one month of use, based on clinical evaluations by dermatologists and self-assessments by patients.